
|
ProQuest Announces Distribution Agreement with The New England Journal of Medicine
World-renowned journal will be available in ProQuest online databases
![]() |
|
ANN ARBOR, Mich., December 10, 2003 - ProQuest Information and Learning has signed a new agreement with The New England Journal of Medicine (NEJM) to distribute the full text of the respected medical journal electronically to libraries, hospitals and educational institutions. ProQuest Information and Learning, a unit of ProQuest Company, creates and publishes databases for libraries and educational institutions worldwide. NEJM is considered the world's gold standard for keeping up to date on the best practices in medicine. A career companion for physicians, it also helps define and reinforce clinical care for physicians in training. Thousands of academics throughout the world use the Journal as a teaching tool. Three out of four readers practice internal medicine or an internal medicine subspecialty, delivering office-based or hospital-based care in 12 core fields: allergy/immunology, cardiology, emergency medicine, endocrinology, gastroenterology, hematology, infectious diseases, nephrology, neurology, oncology, pulmonary disease, and rheumatology. "The highly regarded NEJM will be an excellent addition to ProQuest's medical resources. The goal of both ProQuest and NEJM is to provide the most up-to-date, reliable and balanced medical research available in a way that is useful and convenient," said Steven Hall, Senior Vice President, Publishing for ProQuest Information and Learning. The new agreement allows ProQuest to offer NEJM in several ProQuest® online databases including: ProQuest Research Library, ProQuest 5000, ProQuest Medical Library, Medline with Full Text, CINAHL Database with Full Text, ProQuest Health and Medical Complete, PsycINFO Database with Full Text, XanEdu CoursePacks and eLibraryTM, among others. Backfile rights dating back to 1996 are included in the agreement. Content in XanEdu CoursePacks will be current with the print edition of NEJM. Other databases will be embargoed 90 days. Full text and Text+ GraphicsTM formats will be used in all services. Subscribers can sign up for the ProQuest specialized email notification lists at: http://www.proquest.com/en-US/site/forms/mailinglist.shtml to receive notification when the full-text title is loaded and available. Free trials are available. Libraries may receive more information by contacting their account representative at 1-800-521-0600, ext. 3183 or 3452 or pqsales@il.proquest.com. (Outside the U.S., contact marketing@proquest.co.uk.) Editors may call 1-800-521-0600, ext. 6489 or email pr@il.proquest.com. About The New England Journal of Medicine The New England Journal of Medicine is the most widely read, cited and influential medical journal in the world. More than 500,000 readers in 177 countries rely on the Journal every week for the information they need to provide the best care for their patients. The mission of the Journal is to bring readers the best research at the interface of biomedical science and clinical practice, presented in an understandable and clinically useful format. Led by Editor-in-chief Dr. Jeffrey M. Drazen, it is the oldest continuously published medical periodical. The Journal is owned and published by the Massachusetts Medical Society and has offices in Boston and Waltham, Mass. It can be found on the Web at www.nejm.org. About ProQuest More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others. Inspired by its customers and their end users, ProQuest is working toward a future that blends information accessibility with community to further enhance learning and encourage lifelong enrichment. For more information, visit www.proquest.com or the ProQuest parent company website, www.cig.com. |